Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Early Intervention in Psychiatry
|
September 14, 2019
Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia
Brianne Brown, Ibrahim Turkoz, Branislav Mancevski, et al.
Psychopharmacology Bulletin
|
August 26, 2017
Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder
Brianne Brown, Larry Alphs, Ibrahim Turkoz, et al.
Contemporary Clinical Trials
|
January 31, 2017
Study protocol: The Technology-Enhanced Coaching (TEC) program to improve diabetes outcomes - A randomized controlled trial
Michele Heisler, Rebecca Mase, Brianne Brown, et al.
Birth Defects Research
|
March 14, 2023
Association of prepregnancy body mass index and gestational weight gain on severity of optic nerve hypoplasia
Betty A Situ, Mark S Borchert, Brianne Brown, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 20, 2022
Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study
Anirban Basu, Carmela Benson, Ibrahim Turkoz, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 24, 2023
Real-world calibration and transportability of the Disease Recovery Evaluation and Modification (DREaM) randomized clinical trial in adult Medicaid beneficiaries with recent-onset schizophrenia
Anirban Basu, Charmi Patel, Alex Z Fu, et al.
Schizophrenia Research
|
March 5, 2022
The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder
Larry Alphs, Brianne Brown, Ibrahim Turkoz, et al.
Schizophrenia Research
|
August 8, 2022
Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) study
Larry Alphs, Pamela Baker, Brianne Brown, et al.
Current Medical Research and Opinion
|
July 26, 2017
Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting
Kruti Joshi, Marie-Hélène Lafeuille, Brianne Brown, et al.
Ophthalmology. Retina
|
December 31, 2025
Adjuvant Chemotherapy in Retinoblastoma with Post-laminar Optic Nerve Invasion: A Global Multicenter Study
Michelle Lin, Sarah B Pike, Mark W Reid, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Early Intervention in Psychiatry
|
September 14, 2019
Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia
Brianne Brown, Ibrahim Turkoz, Branislav Mancevski, et al.
Psychopharmacology Bulletin
|
August 26, 2017
Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder
Brianne Brown, Larry Alphs, Ibrahim Turkoz, et al.
Contemporary Clinical Trials
|
January 31, 2017
Study protocol: The Technology-Enhanced Coaching (TEC) program to improve diabetes outcomes - A randomized controlled trial
Michele Heisler, Rebecca Mase, Brianne Brown, et al.
Birth Defects Research
|
March 14, 2023
Association of prepregnancy body mass index and gestational weight gain on severity of optic nerve hypoplasia
Betty A Situ, Mark S Borchert, Brianne Brown, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 20, 2022
Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study
Anirban Basu, Carmela Benson, Ibrahim Turkoz, et al.
Journal of Managed Care & Specialty Pharmacy
|
January 24, 2023
Real-world calibration and transportability of the Disease Recovery Evaluation and Modification (DREaM) randomized clinical trial in adult Medicaid beneficiaries with recent-onset schizophrenia
Anirban Basu, Charmi Patel, Alex Z Fu, et al.
Schizophrenia Research
|
March 5, 2022
The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder
Larry Alphs, Brianne Brown, Ibrahim Turkoz, et al.
Schizophrenia Research
|
August 8, 2022
Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) study
Larry Alphs, Pamela Baker, Brianne Brown, et al.
Current Medical Research and Opinion
|
July 26, 2017
Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting
Kruti Joshi, Marie-Hélène Lafeuille, Brianne Brown, et al.
Ophthalmology. Retina
|
December 31, 2025
Adjuvant Chemotherapy in Retinoblastoma with Post-laminar Optic Nerve Invasion: A Global Multicenter Study
Michelle Lin, Sarah B Pike, Mark W Reid, et al.
Page
of 3